ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,531Medicare Part D Prescriptions Filled, Including Refills

Rank: 137 out of 680

$1.07M Total Retail Price of All Prescriptions

Rank: 68 out of 680

816 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 816 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

8% of this provider’s 816 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 10,811 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 513 442 1 1
HYDROCHLOROTHIAZIDE 493 428 2 9
ATORVASTATIN CALCIUM 442 351 3 11
LEVOTHYROXINE SODIUM 387 366 4 2
FUROSEMIDE 374 296 5 6
LISINOPRIL 346 250 6 5
PANTOPRAZOLE SODIUM 325 270 7 30
METFORMIN HCL 283 229 8 8
ZOLPIDEM TARTRATE 270 174 9 17
HYDROCODONE-ACETAMINOPHEN 270 129 S3 9 4
SIMVASTATIN 248 219 11 3
METOPROLOL TARTRATE 216 185 12 12
METOPROLOL SUCCINATE 204 181 13 13
NEXIUM 204 133 13 16
CITALOPRAM HBR 198 155 15 22
LOVASTATIN 175 163 16 44
WARFARIN SODIUM 171 144 17 20
POTASSIUM CHLORIDE 164 125 18 14
LOSARTAN-HYDROCHLOROTHIAZIDE 159 155 19 51
FLUTICASONE PROPIONATE 148 121 20 41
LOSARTAN POTASSIUM 145 140 21 21
DIOVAN HCT 145 130 21 55
GABAPENTIN 137 96 23 15
ALPRAZOLAM 137 82 23 72
INSULIN SYRINGE 135 105 25 86
MELOXICAM 135 129 25 24
CARVEDILOL 133 119 27 23
TRAMADOL HCL 121 107 28 18
PRAVASTATIN SODIUM 120 92 29 10
DIOVAN 119 98 30 31
AMLODIPINE BESYLATE-BENAZEPRIL 117 94 31 43
ENALAPRIL MALEATE 114 100 32 65
PLAVIX 109 97 33 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 106 68 34 37
RANITIDINE HCL 106 95 34 56
ALENDRONATE SODIUM 105 104 36 32
TRIAMTERENE-HCTZ 105 92 36 52
CLONIDINE HCL 104 96 38 36
CLOPIDOGREL 101 86 39 26
ACTOS 97 91 40 114
GLIMEPIRIDE 92 86 41 29
OMEPRAZOLE 89 68 42 7
GLIPIZIDE 89 88 42 63
NAMENDA 87 87 44 35
CRESTOR 86 67 45 25
PROAIR HFA 82 62 46 67
GLYBURIDE 82 73 R 46 85
BENAZEPRIL HCL 81 73 48 40
ATENOLOL 78 65 49 19
CYMBALTA 76 34 50 46
QUINAPRIL HCL 71 57 51 104
SERTRALINE HCL 69 55 52 28
TAMSULOSIN HCL 69 63 52 34
LANTUS 69 53 52 49
DONEPEZIL HCL 66 66 55 27
LOVAZA 64 55 56 119
ALLOPURINOL 64 53 56 33
AZITHROMYCIN 62 52 58 42
CIPROFLOXACIN HCL 60 54 59 57
TRADJENTA 59 54 60 301
SPIRIVA 59 49 60 70
ADVAIR DISKUS 58 32 62 53
NAPROXEN 57 50 63 121
HYDRALAZINE HCL 57 56 63 71
LORAZEPAM 57 46 63 125
ESCITALOPRAM OXALATE 57 45 63 45
PREDNISONE 54 27 67 50
PIOGLITAZONE HCL 53 41 R 68 276
GEMFIBROZIL 51 36 69 106
DOXAZOSIN MESYLATE 50 39 70 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 16, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.